Aura Biosciences Statistics

Total Valuation

AURA has a market cap or net worth of $355.72 million. The enterprise value is $172.17 million.

Market Cap	355.72M
Enterprise Value	172.17M

Important Dates

The last earnings date was Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

AURA has 49.54 million shares outstanding. The number of shares has increased by 30.88% in one year.

Shares Outstanding	49.54M
Shares Change (YoY)	+30.88%
Shares Change (QoQ)	+10.75%
Owned by Insiders (%)	7.51%
Owned by Institutions (%)	79.10%
Float	30.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.70
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.97, with a Debt / Equity ratio of 0.09.

Current Ratio	21.97
Quick Ratio	n/a
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.80% and return on invested capital (ROIC) is -38.52%.

Return on Equity (ROE)	-41.80%
Return on Assets (ROA)	-36.50%
Return on Capital (ROIC)	-38.52%
Revenue Per Employee	n/a
Profits Per Employee	-$893,727
Employee Count	88
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, AURA has paid $183,000 in taxes.

Income Tax	183,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.34% in the last 52 weeks. The beta is 0.37, so AURA's price volatility has been lower than the market average.

Beta (1Y)	0.37
52-Week Price Change	-36.34%
50-Day Moving Average	7.54
200-Day Moving Average	8.57
Relative Strength Index (RSI)	45.78
Average Volume (30 Days)	184,590

Short Selling Information

The latest short interest is 2.76 million, so 5.58% of the outstanding shares have been sold short.

Short Interest	2.76M
Short Previous Month	2.58M
Short % of Shares Out	5.58%
Short % of Float	9.00%
Short Ratio (days to cover)	23.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-87.86M
Pretax Income	-78.47M
Net Income	-78.65M
EBITDA	-75.00M
EBIT	-78.47M
Earnings Per Share (EPS)	-$1.86

Full Income Statement

Balance Sheet

The company has $202.87 million in cash and $19.32 million in debt, giving a net cash position of $183.55 million or $3.70 per share.

Cash & Cash Equivalents	202.87M
Total Debt	19.32M
Net Cash	183.55M
Net Cash Per Share	$3.70
Equity / Book Value	208.78M
Book Value Per Share	4.21
Working Capital	202.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$71.89 million and capital expenditures -$688,000, giving a free cash flow of -$72.58 million.

Operating Cash Flow	-71.89M
Capital Expenditures	-688,000
Free Cash Flow	-72.58M
FCF Per Share	-$1.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AURA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.88%
Shareholder Yield	-30.88%
Earnings Yield	-22.11%
FCF Yield	-20.40%

Analyst Forecast

The average price target for AURA is $21.00, which is 188.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	188.86%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2